C83.75
Burkitt lymphoma, lymph nodes of inguinal region and lower limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects lymph nodes. When it occurs in the inguinal region and lower limb, it involves the lymph nodes in those areas, which can cause swelling and other symptoms. Despite its fast growth, early diagnosis and treatment can improve outcomes significantly. This article provides an overview of Burkitt lymphoma occurring in these regions, including its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: The exact cause of Burkitt lymphoma isn't fully understood, but several factors have been associated with its development: - **Genetic mutations**: Changes in the DNA of lymphocyte cells can lead to uncontrolled growth. - **Infections**: Epstein-Barr virus (EBV) infection is strongly linked, especially in endemic cases. Human immunodeficiency virus (HIV) infection can also increase risk. - **Immune system suppression**: Conditions or treatments that weaken the immune system may contribute. - **Environmental factors**: Exposure to certain chemicals or toxins might play a role, though evidence is limited.
Key Symptoms: Symptoms of Burkitt lymphoma in the inguinal region and lower limb can include: - **Swelling or a noticeable lump** in the groin or thigh area. - **Pain or tenderness** in the affected region. - **Rapidly enlarging mass** that may grow within days. - **Fever** and night sweats. - **Unintentional weight loss** over a short period. - **Fatigue or weakness.** - **Additional symptoms** might include discomfort or sensation changes depending on local invasion or compression of nearby tissues.
Diagnostic & Treatment
Diagnosis Path: Diagnosing Burkitt lymphoma involves several steps: - **Physical examination**: Checking for enlarged lymph nodes or masses. - **Imaging tests**: Such as ultrasound, CT scans, or MRI to determine the extent of the disease. - **Biopsy**: Removing a tissue sample from the affected lymph node for microscopic examination. The pathology confirms the diagnosis. - **Laboratory tests**: Blood tests to assess overall health and look for signs of lymphoma. - **Additional tests**: Bone marrow biopsy and cerebrospinal fluid analysis might be required to evaluate spread.
Treatment Protocols: The treatment of Burkitt lymphoma typically involves aggressive chemotherapy regimens tailored to the patient's age and overall health. Protocols may include: - **Intensive chemotherapy**: A combination of drugs designed to target rapidly dividing cells. - **Central nervous system prophylaxis**: Because of the risk of spread to the brain and spinal cord. - **Targeted therapy**: In some cases, targeted drugs may be used. - **Supportive care**: Includes managing side effects, infection prevention, and nutritional support. - **Radiation therapy**: Less commonly used but may be considered in specific circumstances. Multidisciplinary care involving hematologists, oncologists, and supportive specialists is essential for optimal management.
Clinical Advice & FAQs
Billing Guidance
Is C83.75 a billable ICD-10 code?
Yes, C83.75 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.75?
Clinical documentation must specify the nature of Burkitt lymphoma, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference